Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia

Published 2010 View Full Article

Authors

Keywords

Journal

CANCER

Volume 117, Issue 1, Pages 116-124

Publisher

Wiley

Online

2010-09-01

DOI

10.1002/cncr.25379

References

View 3 related references

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

CANCER

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Publish scientific posters with Peeref